Promoting Accountability, Transparency, Innovation, Efficiency, and Timeliness at FDA Act of 2012

April 17, 2012
April 17, 2012
Referred to Senate (sub)committee

This bill would streamline the Food and Drug Administration. The only clause relevant to Israel includes it on a list of countries whose citizens are given expanded privileges to investigate copyrighted devices.

1 cosponsor (1R)

Last major action: 4/17/12 referred to Senate Cmte. on Health, Education, Labor, and Pensions.

More info

For more information, Click Here to visit this measure’s page at

Legislation Topics